Qcm Cayman, Ltd. Invitae Corp Transaction History

Qcm Cayman, Ltd.

  • $7.42 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 24, 2023
BUY
$1.2 - $2.73 $22,454 - $51,083
18,712 Added 146.97%
31,444 $42,000
Q4 2022

Jan 30, 2023
BUY
$1.71 - $3.61 $21,771 - $45,962
12,732 New
12,732 $23,000
Q2 2022

Jul 27, 2022
BUY
$2.13 - $9.01 $44,568 - $188,525
20,924 New
20,924 $51,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Qcm Cayman, Ltd. Portfolio

Follow Qcm Cayman, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Qcm Cayman, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email